PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
with the Quarterly Report of Elite Pharmaceuticals, Inc. (the “Registrant”) on Form 10-Q for the quarter ended June
30, 2015 filed with the Securities and Exchange Commission (the “Report”), I, Nasrat Hakim, Chief Executive Officer
of the Registrant, certify, pursuant to 18 U.S. C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that:
Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the
|Date: August 10, 2015
||Chief Executive Officer
||of Elite Pharmaceuticals, Inc.
This certification has been furnished
solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
A signed original of this written
statement required by Section 906 has been provided to Elite Pharmaceuticals, Inc. and will be retained by Elite Pharmaceuticals,
Inc. and furnished to the Securities and Exchange Commission or its staff upon request.